More than 160 speakers and 2,000 registrants from 600 organizations and 30 countries are coming to Boston for the annual World Medical Innovation Forum April 8-10. Hosted by Partners HealthCare Innovation, this year’s forum features industry CEOs, Harvard faculty, investors and technologists exploring the impact of artificial intelligence (AI) on clinical care. The forum covers AI opportunities and impact on disease areas ranging from cancer care, cardiovascular and neurology, to mental health and the opioid crisis.
The forum – co-chaired by Anne Klibanski, MD, interim president and CEO of Partners HealthCare, and Gregg Meyer, MD, Partners chief clinical officer – also features provider AI strategies, 50 AI medical application use cases, and clinical and technology visionaries imagining medicine in 2054. The forum was established five years ago to respond to the intensifying transformation of health care and its impact on innovation. It is rooted in the belief that no matter the magnitude of that change, the center of health care needs to be a shared, fundamental commitment to collaborative innovation – industry and academia working together to improve patient lives.
For more information and to register, visit https://worldmedicalinnovation.org/.
Read more articles from the 03/08/19 Hotline issue.